These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9487143)

  • 1. The inhibition of cell signaling pathways by antitumor ether lipids.
    Arthur G; Bittman R
    Biochim Biophys Acta; 1998 Feb; 1390(1):85-102. PubMed ID: 9487143
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitumor ether lipids: endocytosis as a determinant of cellular sensitivity.
    Workman P
    Cancer Cells; 1991 Aug; 3(8):315-7. PubMed ID: 1657088
    [No Abstract]   [Full Text] [Related]  

  • 3. Ether lipids and analogues.
    Fleer EA
    J Cancer Res Clin Oncol; 1988; 114(6):655-6. PubMed ID: 3204115
    [No Abstract]   [Full Text] [Related]  

  • 4. Antitumor activity of SRI 62-834, a cyclic ether analog of ET-18-OCH3.
    Houlihan WJ; Lee ML; Munder PG; Nemecek GM; Handley DA; Winslow CM; Happy J; Jaeggi C
    Lipids; 1987 Nov; 22(11):884-90. PubMed ID: 2832680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines.
    Civoli F; Daniel LW
    Cancer Chemother Pharmacol; 1998; 42(4):319-26. PubMed ID: 9744778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavonoid-alkylphospholipid conjugates elicit dual inhibition of cancer cell growth and lipid accumulation.
    Zhou Z; Luo B; Liu X; Chen M; Lan W; Iovanna JL; Peng L; Xia Y
    Chem Commun (Camb); 2019 Aug; 55(61):8919-8922. PubMed ID: 31270526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis.
    Ruiter GA; Zerp SF; Bartelink H; van Blitterswijk WJ; Verheij M
    Cancer Res; 1999 May; 59(10):2457-63. PubMed ID: 10344758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological changes of adherent and nonadherent cells by treatment with hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine observed by scanning electron microscopy.
    Kaufmann-Kolle P; Fleer EA
    Prog Exp Tumor Res; 1992; 34():47-58. PubMed ID: 1438802
    [No Abstract]   [Full Text] [Related]  

  • 9. Hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine: a comparison of hemolytic activity, serum binding and tissue distribution.
    Kötting J; Marschner NW; Neumüller W; Unger C; Eibl H
    Prog Exp Tumor Res; 1992; 34():131-42. PubMed ID: 1438796
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of intracellular free calcium mobilization in the mechanism of action of antitumour ether lipids SRI 62-834 and ET18-OMe.
    Lohmeyer M; Workman P
    Biochem Pharmacol; 1993 Jan; 45(1):77-86. PubMed ID: 8424826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer mechanisms and clinical application of alkylphospholipids.
    van Blitterswijk WJ; Verheij M
    Biochim Biophys Acta; 2013 Mar; 1831(3):663-74. PubMed ID: 23137567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ether lipids are effective cytotoxic drugs against multidrug-resistant acute leukemia cells and can act by the induction of apoptosis.
    Verdonck LF; van Heugten HG
    Leuk Res; 1997 Jan; 21(1):37-43. PubMed ID: 9029184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects.
    van Blitterswijk WJ; Verheij M
    Curr Pharm Des; 2008; 14(21):2061-74. PubMed ID: 18691116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ether lipids enhance the cytotoxic effect of teniposide and paclitaxel in liposomes against leukaemic cells in culture.
    Lundberg BB
    Anticancer Drug Des; 1997 Sep; 12(6):503-13. PubMed ID: 9311558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ether lipids on mouse granulocyte-macrophage progenitor cells.
    Vehmeyer K; Kim DJ; Nagel GA; Eibl H; Unger C
    Cancer Chemother Pharmacol; 1989; 24(1):58-60. PubMed ID: 2720891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic etherphospholipid analogues.
    Berkovic D
    Gen Pharmacol; 1998 Oct; 31(4):511-7. PubMed ID: 9792208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei.
    Croft SL; Snowdon D; Yardley V
    J Antimicrob Chemother; 1996 Dec; 38(6):1041-7. PubMed ID: 9023651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple effects of antitumor alkyl-lysophospholipid analogs on the cytosolic free Ca2+ concentration in a normal and a breast cancer cell line.
    Bergmann J; Junghahn I; Brachwitz H; Langen P
    Anticancer Res; 1994; 14(4A):1549-56. PubMed ID: 7979184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An antagonist to platelet activating factor counteracts the tumoricidal action of alkyl lysophospholipids.
    Bazill GW; Dexter TM
    Biochem Pharmacol; 1989 Jan; 38(2):374-7. PubMed ID: 2536543
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells.
    Dive C; Watson JV; Workman P
    Cancer Res; 1991 Feb; 51(3):799-806. PubMed ID: 1988120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.